Sanara MedTech (SMTI) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for May 22, 2025, will be held virtually to enhance shareholder participation and reduce costs.

• Shareholders will vote on the election of eight directors and the ratification of the independent auditor for 2025.

• Proxy materials, including the 2024 Annual Report, are available online and by mail.

Voting matters and shareholder proposals

• Proposal 1: Election of eight directors to serve until the 2026 annual meeting.

• Proposal 2: Ratification of Weaver and Tidwell, L.L.P. as independent registered public accounting firm for 2025.

• Board recommends voting FOR all director nominees and FOR auditor ratification.

• Shareholders may submit proposals for the 2026 meeting by December 22, 2025.

Board of directors and corporate governance

• Board consists of eight members, majority of whom are independent under Nasdaq rules.

• Committees include audit, compensation, nominating and corporate governance, and corporate development.

• Board leadership combines CEO and Executive Chairman roles; no lead independent director.

• Code of Ethics applies to all directors, officers, and employees.